Ligand Pharmaceuticals Incorporated (LGND) Stock Analysis

Ligand Pharmaceuticals Incorporated (LGND) is a publicly traded company in the HEALTHCARE sector. It trades at $232.76, carries a market capitalization of $4.61B, a price-to-earnings ratio of 29.96. This page summarizes the public market data, fundamentals, and frequently asked questions for LGND, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Ligand Pharmaceuticals Incorporated currently has a Neutral sentiment score of 0.07.

About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated is a prominent biopharmaceutical company based in San Diego, California, dedicated to advancing drug discovery and development through its innovative technologies tailored for pharmaceutical partners worldwide. The company's extensive portfolio of proprietary solutions enables it to enhance drug efficacy and streamline market access across various therapeutic areas. With a strategic focus on collaboration and a seasoned management team, Ligand is uniquely p...

GNG Research Analysis

GNG Research scores Ligand Pharmaceuticals Incorporated (LGND) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for LGND.

Frequently Asked Questions

Does LGND pay dividends?

Ligand Pharmaceuticals Incorporated (LGND) does not currently pay a regular dividend.

What is LGND's P/E ratio?

Ligand Pharmaceuticals Incorporated has a price-to-earnings (P/E) ratio of 29.96.

What is LGND's market cap?

Ligand Pharmaceuticals Incorporated (LGND) has a market capitalization of $4.61B with a current stock price of $232.76.